catechin has been researched along with lithium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azzolin, VF; Barbisan, F; da Cruz, IBM; do Prado-Lima, PAS; Mastella, MH; Medeiros Frescura Duarte, MM; Praia, RS; Ribeiro, EE; Teixeira, CF | 1 |
| Cui, Z; Jia, L; Qu, Z; Si, P; Sun, C; Wang, W; Xie, T; Xue, Y; Zhen, J | 1 |
2 other study(ies) available for catechin and lithium
| Article | Year |
|---|---|
Xanthine-Catechin Mixture Enhances Lithium-Induced Anti-Inflammatory Response in Activated Macrophages
Topics: Animals; Anti-Inflammatory Agents; Catechin; Cell Cycle; Cell Proliferation; Cytokines; Drug Interactions; Drug Synergism; Lithium; Macrophages; Mice; RAW 264.7 Cells; Xanthine | 2017 |
(-)-Epigallocatechin-3-Gallate Protects Against Lithium-Pilocarpine-Induced Epilepsy by Inhibiting the Toll-Like Receptor 4 (TLR4)/Nuclear Factor-κB (NF-κB) Signaling Pathway.
Topics: Animals; Catechin; Disease Models, Animal; Epilepsy; Epilepsy, Temporal Lobe; Hippocampus; Lithium; Long-Term Potentiation; Male; Neurons; Neuroprotective Agents; NF-kappa B; Pilocarpine; Rats; Rats, Sprague-Dawley; Seizures; Signal Transduction; Toll-Like Receptor 4 | 2019 |